Quality of life in patients with B-cell lymphoma during maintenance therapy with the Anti-CD20 antibody rituximab

被引：0
|
作者：
Witzens-Harig, Mathias [1 ]
Heiss, Christiane [2 ]
Benner, Axel [2 ]
Hensel, Manfred [1 ]
Neben, Kai [1 ]
Dreger, Peter [1 ]
Kraemer, Alwin [1 ]
Ho, Anthony D. [1 ]
机构：
[1] Univ Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany
[2] German Canc Res Ctr, Dept Biostat, Heidelberg, Germany
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4471.4471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4471
引用
收藏
页码：189B / 189B
页数：1
相关论文
共 50 条
  • [1] Quality of life in patients with Non-Hodgkins-Lymphoma during maintenance therapy with the anti-CD20 antibody rituximab
    Witzens-Harig, M.
    Reiz, M.
    Heiss, C.
    Benner, A.
    Hensel, M.
    Neben, K.
    Dreger, P.
    Kraemer, A.
    Ho, A. D.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 108 - 108
  • [2] Maintenance therapy using the anti-CD20 antibody Rituximab in patients with B-cell non-Hodgkin lymphoma
    Neumann, F
    Martin, S
    Kronenwett, R
    Fischer, C
    Kondakci, M
    Kobbe, G
    Gattermann, N
    Haas, R
    BLOOD, 2003, 102 (11) : 298B - 298B
  • [3] Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma
    Heinzerling, L
    Dummer, R
    Kempf, W
    Schmid, MH
    Burg, G
    ARCHIVES OF DERMATOLOGY, 2000, 136 (03) : 374 - 378
  • [4] Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial
    Witzens-Harig, Mathias
    Reiz, Monika
    Heiss, Christiane
    Benner, Axel
    Hensel, Manfred
    Neben, Kai
    Dreger, Peter
    Kraemer, Alwin
    Ho, Anthony D.
    ANNALS OF HEMATOLOGY, 2009, 88 (01) : 51 - 57
  • [5] Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin’s lymphoma: results of a prospective randomized controlled trial
    Mathias Witzens-Harig
    Monika Reiz
    Christiane Heiß
    Axel Benner
    Manfred Hensel
    Kai Neben
    Peter Dreger
    Alwin Kraemer
    Anthony D. Ho
    Annals of Hematology, 2009, 88
  • [6] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Calcagno, Andrea
    Rostagno, Roberto
    Di Perri, Giovanni
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 877 - 878
  • [7] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (21): : 2008 - 2016
  • [8] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [9] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    International Journal of Hematology, 2002, 76 : 411 - 419
  • [10] Intralesional therapy with anti-CD20 monoclonal antibody rituximab: local and systemic efficacy in primary cutaneous B-cell lymphoma
    Roguedas, AM
    Watier, H
    Paintaud, G
    de Muret, A
    Vaillant, L
    Machet, L
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (03) : 541 - 544
12345